11 subscribers
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
Recapping the 2025 J.P. Morgan Healthcare Conference
Manage episode 462949939 series 3386301
This year’s edition of the annual J.P. Morgan Healthcare Conference has come to a close, with attendees enjoying sunny skies and a heavy police presence throughout the San Francisco-set event.
In this week’s episode of The Top Line, Fierce Pharma’s Zoey Becker and Angus Liu join Fierce Biotech’s Darren Incorvaia to break down the biggest news stories out of the conference. From Johnson & Johnson’s blockbuster acquisition of Intra-Cellular Therapies to former First Lady Jill Biden’s appearance at Fierce JPM Week just days before she left the White House, this year’s conference set the stage for what will surely be an eventful 2025.
To learn more about the topics in this episode:
- ‘Own JP Morgan, don't let JP Morgan own you’: Biopharma—and Jill Biden—show up for JPM25
- JPM25: Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B
- JPM25: First Lady Jill Biden committed to improving women's health as White House tenure winds down
- JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
- GSK-backed Ouro Medicines launches into T-cell engager space with $120M and a clinical-stage asset
This episode is brought to you by Cencora. Learn more at cencora.com/breakthrough.
See omnystudio.com/listener for privacy information.
102 حلقات
Manage episode 462949939 series 3386301
This year’s edition of the annual J.P. Morgan Healthcare Conference has come to a close, with attendees enjoying sunny skies and a heavy police presence throughout the San Francisco-set event.
In this week’s episode of The Top Line, Fierce Pharma’s Zoey Becker and Angus Liu join Fierce Biotech’s Darren Incorvaia to break down the biggest news stories out of the conference. From Johnson & Johnson’s blockbuster acquisition of Intra-Cellular Therapies to former First Lady Jill Biden’s appearance at Fierce JPM Week just days before she left the White House, this year’s conference set the stage for what will surely be an eventful 2025.
To learn more about the topics in this episode:
- ‘Own JP Morgan, don't let JP Morgan own you’: Biopharma—and Jill Biden—show up for JPM25
- JPM25: Johnson & Johnson makes a splash, buying out Intra-Cellular Therapies for $14.6B
- JPM25: First Lady Jill Biden committed to improving women's health as White House tenure winds down
- JPM25: Strategist GSK acquires IDRx for $1B in hopes of bringing GIST patients new standard of care
- GSK-backed Ouro Medicines launches into T-cell engager space with $120M and a clinical-stage asset
This episode is brought to you by Cencora. Learn more at cencora.com/breakthrough.
See omnystudio.com/listener for privacy information.
102 حلقات
كل الحلقات
×
1 Research reveals ‘ticking DNA clock’ behind Huntington’s disease 19:28

1 What were the biggest clinical trial flops of 2024? 10:17

1 A heartwarming roundup of cardiovascular news and most-loved stories 12:05

1 Looking ahead at the most anticipated drug launches of 2025 14:07

1 What to expect from the biotech IPO market in 2025 34:06

1 Recapping the 2025 J.P. Morgan Healthcare Conference 20:47

1 Fierce's forecasts for the next year in biopharma 25:10

1 An additional treatment option with TAGRISSO® (osimertinib) (Sponsored) 14:25

1 Breaking down the 55 new drug approvals of 2024 13:03

1 Fierce 50 honorees look ahead: AI, rural health, antibiotic resistance, maternal care and more 39:41

1 Novo Nordisk’s chief scientific officer looks to the future of GLP-1s 32:45

1 What can we learn from 2024’s biotech IPOs? 15:06

1 Meet 2024’s fiercest women in life sciences 12:30

1 Misconduct and the future of neurodegenerative disease research 15:29

1 Dig into this year’s Fierce Biotech Graveyard, layoff numbers 11:51
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.